A bibliometric analysis of scientific production in cancer molecular epidemiology.

OBJECTIVES The main purpose of this research was to compare the scientific production in the field of cancer molecular epidemiology among countries and to evaluate the publication trend between 1995 and 2004. METHODS A bibliometric study was carried out searching the PubMed database with a combined search strategy based on the keywords listed in the medical subject headings and a free text search. Only articles from a representative subset of 92 journals--accounting for 80% of papers identified--were selected for the analysis, and the resulting 13,240 abstracts were manually checked according to a list of basic inclusion criteria. The study evaluated the number of publications and the impact factor (mean and sum), absolute and normalized by country population and gross domestic product. RESULTS A total of 3,842 citations were finally selected for the analysis. Thirty-seven percent came from the European Union (UK, Germany, Italy, France and Sweden ranking at the top), 31.6% from USA and 9.7% from Japan. The highest mean impact factor was reported for Canada (6.3), USA (5.9), Finland (5.8) and UK (5.2). Finland, Sweden and Israel had the best ratio between scientific production and available resources. 'Genetic polymorphism, glutathione transferase, breast neoplasm, risk factors, case-control studies and polymerase chain reaction' were the most used keywords in each of the subgroups evaluated, although inclusion criteria may have privileged studies dealing with exogenous carcinogens. CONCLUSION Cancer molecular epidemiology is an expanding area attracting an increasing interest. The identification of an operative definition is a necessary condition to give to this discipline a unique scientific identity.

[1]  D. King.  The scientific impact of nations , 2004, Nature.

[2]  A. Benzer,et al.  Geographical analysis of medical publications in 1990 , 1993, The Lancet.

[3]  P. Kam.  Impact Factor: Overrated and Misused? , 2005, Anaesthesia and intensive care.

[4]  F P Perera,et al.  Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. , 1982, Journal of chronic diseases.

[5]  Donatella Ugolini,et al.  Trends in otolaryngology research during the period 1995-2000: A bibliometric approach , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[6]  A. Håkansson.  The Impact Factor – a dubious measure of scientific quality , 2005, Scandinavian journal of primary health care.

[7]  O. Belvedere,et al.  Geography of clinical cancer research publications from 1995 to 1999. , 2003, European journal of cancer.

[8]  E. Garfield.  The history and meaning of the journal impact factor. , 2006, JAMA.

[9]  S. Bonassi,et al.  Searching PubMed for molecular epidemiology studies: The case of chromosome aberrations , 2006, Environmental and molecular mutagenesis.

[10]  Estimates of global research productivity in virology , 2005, Journal of medical virology.

[11]  Europe.,et al.  In Europe … , 1994, Current History.

[12]  F P Perera,et al.  Molecular epidemiology: recent advances and future directions. , 2000, Carcinogenesis.

[13]  Mahbubur Rahman,et al.  Research articles published in clinical radiology journals: trend of contribution from different countries. , 2005, Academic radiology.

[14]  D Ugolini,et al.  Oncological research overview in the European Union. A 5-year survey. , 2003, European journal of cancer.

[15]  Paul A. Schulte,et al.  Molecular epidemiology : principles and practices , 1993 .

[16]  Tsuguya Fukui,et al.  BIOMEDICAL RESEARCH PRODUCTIVITY , 2003, International Journal of Technology Assessment in Health Care.

[17]  M. Falagas,et al.  A bibliometric analysis of global research production in respiratory medicine. , 2005, Chest.

[18]  Kai Simons,et al.  Science in Europe , 2000, Science.

[19]  Marco Amedeo Cimmino,et al.  How the European Union writes about ophthalmology , 2001, Scientometrics.

[20]  G S Mela,et al.  An overview of rheumatological research in the European Union , 1998, Annals of the rheumatic diseases.

[21]  M. Kirsch‐Volders,et al.  Human population studies with cytogenetic biomarkers: Review of the literature and future prospectives , 2005, Environmental and molecular mutagenesis.